Tibor Keler, Executive VP & CSO at Celldex Therapeutics, Inc. (CLDX), bought 3,000 shares at $3.32 ($10K) on 2016-09-02, disclosed to the SEC on 2016-09-06.
Open-market purchase of $10k CLDX by Executive VP & CSO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| CLDX | BUY | 2018-06-18 | $10K | — | Filing → |
| CLDX | BUY | 2011-08-11 | $13K | — | Filing → |
| CLDX | BUY | 2010-09-13 | $18K | — | Filing → |